The Experimental TASK-1 Potassium Channel Inhibitor A293 Can Be Employed for Rhythm Control of Persistent Atrial Fibrillation in a Translational Large Animal Model

by Hélène Le Ribeuz, Hélène Le Ribeuz, Hélène Le Ribeuz, David Montani, David Montani, David Montani, Fabrice Antigny, Fabrice Antigny, Fabrice Antigny
Published 2021-04-01

Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension

by Hélène Le Ribeuz, Véronique Capuano, Barbara Girerd, Marc Humbert, David Montani, Fabrice Antigny
Published 2020-09-01

In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression

by Hélène Le Ribeuz, Audrey Courboulin, Maria-Rosa Ghigna, Mélanie Lambert, Aurélie Hautefort, Marc Humbert, David Montani, Sylvia Cohen-Kaminsky, Frédéric Perros, Fabrice Antigny
Published 2020-07-01

Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular Cells

by Hélène Le Ribeuz, Florent Dumont, Guillaume Ruellou, Mélanie Lambert, Thierry Balliau, Marceau Quatredeniers, Barbara Girerd, Sylvia Cohen-Kaminsky, Olaf Mercier, Stéphanie Yen-Nicolaÿ, Marc Humbert, David Montani, Véronique Capuano, Fabrice Antigny
Published 2020-10-01